You have 9 free searches left this month | to do more

bocidelpar

Bocidelpar is a drug used to treat Duchenne Muscular Dystrophy (DMD), Healthy Volunteers, Hepatic Impairment, and other conditions. Bocidelpar is being actively studied in 3 studies and prior, has been studied in 1.

Top SponsorsTop SitesTop Investigators
Astellas Pharma Global Development, Inc.Advanced Pharma CR, LLC
Astellas Pharma IncAkron Children's Hospital
Baylor College of Medicine
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
A Study to Evaluate ASP0367 in Participants With Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction
Recruiting
  • Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction
  • Bocidelpar
  • Placebo
  • Boston, Massachusetts
    Brigham and Women's Hospital
2022-03-17
Mar 17, 2022
A
A Study to Evaluate ASP0367 in Participants With Mild/Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function - 2022
Completed
  • Hepatic Impairment
  • Healthy Volunteers
  • Bocidelpar
  • Miami, Florida
  • +2 more
2022-02-04
Feb 4, 2022
A
A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy
Recruiting
  • Primary Mitochondrial Myopathy
  • Bocidelpar
  • Placebo
  • Phoenix, Arizona
  • +12 more
2022-03-29
Mar 29, 2022
A
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)
Recruiting
  • Duchenne Muscular Dystrophy (DMD)
  • Bocidelpar
  • Placebo
  • Los Angeles, California
  • +8 more
2022-03-17
Mar 17, 2022